125 related articles for article (PubMed ID: 36287388)
1. Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France.
Fauvelle K; Bigna JJ
Drug Saf; 2023 Feb; 46(2):121-128. PubMed ID: 36287388
[TBL] [Abstract][Full Text] [Related]
2. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
3. Correction: Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France.
Fauvelle K; Bigna JJ
Drug Saf; 2023 Mar; 46(3):323. PubMed ID: 36538239
[No Abstract] [Full Text] [Related]
4. The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium.
Bertels X; Mehuys E; Boussery K; Lahousse L
Acta Clin Belg; 2022 Oct; 77(5):815-822. PubMed ID: 34569444
[TBL] [Abstract][Full Text] [Related]
5. Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020.
Scholz K; Köster I; Meyer I; Selke GW; Schubert I
Pharmacoepidemiol Drug Saf; 2023 Nov; 32(11):1306-1314. PubMed ID: 37485793
[TBL] [Abstract][Full Text] [Related]
6. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
7. Use of Valproate in Women: An Audit of Prescriptions to 10,001 Psychiatry, Neurology, and Neurosurgery Outpatients.
Andrade C; Jyothi SA; Renitha T; Anuroopa KP; Dona B; Basila T; Nimmy G
J Clin Psychiatry; 2021 Nov; 83(1):. PubMed ID: 34813688
[No Abstract] [Full Text] [Related]
8. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].
Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM
Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK.
Ehlken B; Nishikawa C; Kaplan S; Dresco I; Granados D; Toussi M
Curr Med Res Opin; 2022 Mar; 38(3):461-468. PubMed ID: 34931552
[TBL] [Abstract][Full Text] [Related]
10. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
[TBL] [Abstract][Full Text] [Related]
11. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from Spain.
Ehlken B; Stevanovic I; Kaplan S; Dresco I; Granados D; Toussi M
Rev Neurol; 2021 Dec; 73(11):373-382. PubMed ID: 34826330
[TBL] [Abstract][Full Text] [Related]
13. Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
Angus-Leppan H; Moghim MM; Cock H; Kinton L; Synnott Wells M; Shankar R
Acta Neurol Scand; 2020 Jun; 141(6):483-490. PubMed ID: 32072612
[TBL] [Abstract][Full Text] [Related]
14. Drug-dispensing problems community pharmacists face when patients are discharged from hospitals: a study about 537 prescriptions in Alsace.
Michel B; Hemery M; Rybarczyk-Vigouret MC; Wehrlé P; Beck M
Int J Qual Health Care; 2016 Dec; 28(6):779-784. PubMed ID: 27655792
[TBL] [Abstract][Full Text] [Related]
15. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
[TBL] [Abstract][Full Text] [Related]
16. Patterns in Psychiatrists' Prescription of Valproate for Female Patients of Childbearing Age With Bipolar Disorder in Japan: A Questionnaire Survey.
Tachibana M; Hashimoto T; Tanaka M; Watanabe H; Sato Y; Takeuchi T; Terao T; Kimura S; Koyama A; Ebisawa S; Shizu Y; Nagase T; Hirakawa J; Hatta K; Nakazato M; Iyo M
Front Psychiatry; 2020; 11():250. PubMed ID: 32351410
[TBL] [Abstract][Full Text] [Related]
17. Awareness, knowledge and practice of healthcare professionals following implementation of a Pregnancy Prevention Program for sodium valproate in Ireland: a multi-stakeholder cross-sectional study.
Hughes JE; Buckley N; Looney Y; Kirwan G; Curran S; Doherty CP; Mullooly M; Bennett KE
Expert Opin Drug Saf; 2021 Aug; 20(8):965-977. PubMed ID: 34080507
[TBL] [Abstract][Full Text] [Related]
18. Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016.
Charlton R; Damase-Michel C; Hurault-Delarue C; Gini R; Loane M; Pierini A; Puccini A; Neville A; Snowball J; Morris JK;
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1519-1528. PubMed ID: 31452307
[TBL] [Abstract][Full Text] [Related]
19. Brief intervention reduces prescription of sodium valproate in women of childbearing age.
Goldspink R; Pumipi T; Menkes DB
Australas Psychiatry; 2023 Aug; 31(4):524-527. PubMed ID: 37035997
[TBL] [Abstract][Full Text] [Related]
20. The Awareness and Adherence of the Valproate Pregnancy Prevention Program: A Questionnaire Survey among Healthcare Professionals, Pharmacists, and Patients in Denmark.
Oliveri NMB; Hansen JM; Almarsdóttir AB; Jacobsen R
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
